IP Library Granted Patent US 7,189,841
Granted Patent B2
US 7,189,841 · App. 10/910,463 · Granted Mar 13, 2007

Method for tapping the immunological repertoire

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,189,841
App. No.
10/910,463
Granted
Mar 13, 2007
Kind
B2
Abstract

The present invention relates to a method for isolating from the immunological gene repertoire a gene coding for a receptor having the ability to bind a preselected ligand. Receptors produced by the gene isolated by the method, particularly catalytic receptors, are also contemplated.

Claims (5)

1. A degenerate 5′ primer that hybridizes to a region of a V H immunoglobulin domain, wherein the primer consists of 15 to 25 nucleotides and is substantially complementary to a nucleotide sequence conserved in any one of the leader or first framework regions.

2. The primer of claim 1 , wherein the region is the first framework of the variable region.

3. The primer of claim 1 , wherein the primer consists of the sequence of 5′-AGGT(C/G)(C/A)A(G/A)CT(G/T)CTCGAGTC(T/A)GG-3′.

4. The primer of claim 1 , wherein the primer comprises a nucleotide sequence defining an endonuclease recognition site.

5. A pair of primers suitable for amplifying a V H -coding region, wherein the first primer is a primer according to claim 1 , and wherein the second primer hybridizes with a nucleotide sequence conserved at the 5′ end of the non-coding strand.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 2, 2018
From: MEDICAL RESEARCH COUNCIL
To: UNITED KINGDOM RESEARCH AND INNOVATION
Reel/Frame 046469/0108 →